CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 209 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | -75.0% | 187 | -70.4% | 0.00% | – |
| Q3 2019 | $8,000 | +33.3% | 632 | +6.8% | 0.00% | – |
| Q2 2019 | $6,000 | -85.4% | 592 | -82.9% | 0.00% | – |
| Q1 2019 | $41,000 | -67.2% | 3,456 | -63.3% | 0.00% | -100.0% |
| Q4 2018 | $125,000 | -20.9% | 9,415 | -16.9% | 0.00% | -50.0% |
| Q3 2018 | $158,000 | -12.2% | 11,325 | -1.2% | 0.00% | 0.0% |
| Q2 2018 | $180,000 | +39.5% | 11,468 | +46.6% | 0.00% | 0.0% |
| Q1 2018 | $129,000 | -46.0% | 7,823 | -40.6% | 0.00% | -33.3% |
| Q4 2017 | $239,000 | +334.5% | 13,173 | +355.0% | 0.00% | +200.0% |
| Q3 2017 | $55,000 | -5.2% | 2,895 | -41.4% | 0.00% | 0.0% |
| Q2 2017 | $58,000 | +383.3% | 4,938 | +337.8% | 0.00% | – |
| Q1 2017 | $12,000 | – | 1,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |